Navidea Biopharmaceuticals

$1.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-8.42%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell NAVB and other stocks, options, and ETFs commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate.

CEO
Jed Andrew Latkin
Employees
18
Headquarters
Dublin, Ohio
Founded
1983
Market Cap
49.45M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
377.29K
High Today
$1.88
Low Today
$1.64
Open Price
$1.88
Volume
387.94K
52 Week High
$5.36
52 Week Low
$0.63

NAVB Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

BLMN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure